# Relay Therapeutics (RLAY) — News

RLAY · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/rlay/news

## Recent headlines

- [X-Chem announces phase 3 milestone in collaboration with Relay Therapeutics](https://www.ainvest.com/news/chem-announces-phase-3-milestone-collaboration-relay-therapeutics-2609) — AInvest Wire, Sep 22, 2026
  X-Chem Pharmaceuticals has announced the achievement of a phase 3 milestone in its ongoing collaboration with Relay Therapeutics, marking a significant step in the development of a novel therapeutic candidate. The milestone, which pertains to the completion of a key preclinical study, was reached…
- [Relay Therapeutics - increases at-the-market offering program to $462.98 mln - SEC filing](https://www.ainvest.com/news/relay-therapeutics-increases-market-offering-program-462-98-mln-sec-filing-2608) — AInvest Wire, Aug 6, 2026
- **Important** — [Relay Therapeutics shares extend gains to rally 14%](https://www.ainvest.com/news/relay-therapeutics-shares-extend-gains-rally-14-2606) — AInvest Wire, Jun 2, 2026
- [Relay Therapeutics 22.9M shares at $12.00/shr](https://www.ainvest.com/news/relay-therapeutics-22-9m-shares-12-00-shr-2605) — AInvest Wire, May 21, 2026
  Relay Therapeutics has announced plans to offer 22.9 million shares at a price of $12.00 per share. The offering is part of the company’s broader strategy to raise capital for ongoing operations and research and development initiatives. The terms of the offering, including the number of shares and…
- [Relay Therapeutics prices offering of stock](https://www.ainvest.com/news/relay-therapeutics-prices-offering-stock-2605) — AInvest Wire, May 21, 2026
  Relay Therapeutics, Inc. (Nasdaq: RLAY) has announced the pricing of a public offering of 11,320,755 shares of its common stock at $26.50 per share, with gross proceeds expected to reach approximately $300.0 million before underwriting discounts and expenses. The company also granted the…

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).